ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00931801
Brief Title: BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. (BATAR)

First Submitted : June 30, 2009
First Submitted that Met QC Criteria : July 1, 2009
First Posted : July 2, 2009 (Estimate)

Results First Submitted : February 5, 2013
Results First Submitted that Met QC Criteria : February 5, 2013
Results First Posted : March 11, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : July 18, 2017
Last Update Posted : July 21, 2017